Shopping Cart
Remove All
Your shopping cart is currently empty
Azelnidipine (UR-12592) is a dihydropyridine used as calcium channel blocker.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $30 | In Stock | In Stock | |
| 5 mg | $44 | In Stock | In Stock | |
| 10 mg | $62 | In Stock | In Stock | |
| 25 mg | $111 | In Stock | In Stock | |
| 50 mg | $179 | In Stock | In Stock | |
| 100 mg | $289 | In Stock | In Stock | |
| 200 mg | $428 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $57 | In Stock | In Stock |
| Description | Azelnidipine (UR-12592) is a dihydropyridine used as calcium channel blocker. |
| In vivo | Studies indicate that Azelnidipine, as a new-generation calcium channel blocker, can treat hypertension regardless of the patient's risk for ischemic heart disease. This novel, long-acting calcium channel blocker exhibits unique pharmacological properties, such as a slower heart rate and high affinity for vascular tissue, distinguishing it from other calcium channel blockers. Additionally, the high lipophilicity of Azelnidipine allows it to remain active in the vascular wall even after being cleared from the bloodstream. |
| Synonyms | UR-12592, CS 905 |
| Molecular Weight | 582.65 |
| Formula | C33H34N4O6 |
| Cas No. | 123524-52-7 |
| Smiles | O=C(C1=C(N)NC(C)=C(C(OC(C)C)=O)C1C2=CC([N+]([O-])=O)=CC=C2)OC3CN(C3)C(C4=CC=CC=C4)C5=CC=CC=C5 |
| Relative Density. | 1.33 g/cm3 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: 7 mg/mL (12.01 mM), Sonication is recommended. DMSO: 108 mg/mL (185.36 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (6.87 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.